Skip to main content
OpenTrials
Completed

NCT Number: NCT02213055

Pediatric Head Lice Study Product Comparison

* To evaluate the efficacy of LiceMD for the treatment of head lice in a pediatric population. * To evaluate the safety of LiceMD in a pediatric population.

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Hackensack University Medical Center

Hackensack, New Jersey, 07601, United States

About this study

Head lice, or Pediculus humanus capitis, cause an estimated 6 to 12 million infestations per year in the U.S., most commonly affecting children 3 to 11 years of age. Despite common perceptions, head lice crawl, and cannot hop or fly. For this reason, transmission occurs most often by human head-to-head contact, and much less commonly by the sharing of personal items such as hats, coats, combs, or towels. Because head lice feed on human blood, they cannot live on pets and are only viable 1-2 days on surfaces other than the human head.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject Inclusion Criteria
  • Current lice infestation, confirmed by school nurse. Must have live lice - not just eggs. A minimum of one live louse and 10 viable eggs must be seen or three live lice.
  • Male or female child; age 3 - 12
  • Willing to participate in study, and parent/guardian sign informed consent
  • Parent/guardian must be able to read and follow directions and complete all questionnaires
  • For children/parents who agree to the experimental arm of the study, agree not to use any other head lice product or home remedy lice treatment during the study.

Exclusion criteria

  • No live lice, only eggs.
  • Less than three live lice observed with less than ten viable eggs
  • No hair on the head
  • Buzz cut or crew cut
  • Use of other lice treatment or home remedy lice treatment within the past 4 weeks
  • Chronic scalp disorder (such as psoriasis) that would limit the school nurse's ability to detect lice and/or identify adverse events
  • Currently taking an antibiotic
  • Does not follow instructions.

Treatment and study plan

LICEMD

Drug

Parents/guardians of infested children will provide consent for their child's participation. Infested children whose parents agree to use the investigational product will be enrolled on the experimental arm of the study using the LiceMD product as treatment. Participants will be examined for lice count and scalp irritation the day after the first application, and one and two weeks after the first application.

Other names: Generic Name: Dimethicone

Standard Head lice product

Drug

The most common treatments are pesticide-based, over-the-counter remedies of permethrin (1%), or pyrethrin-based products.After baseline scalp exam for lice count and preexisting signs of irritation, parents who agree to the comparison arm may purchase any other head lice treatment of their choice. All treatments are to be done at home by a parent or guardian. All participants will be examined for lice count and scalp irritation the day after the first application, and one and two weeks after the first application. Participants may also be examined by parents or the school nurse at any time if signs of irritation or re-infestation occur. If the child is still found to be infested during any examination, the school nurse will instruct the parent/guardian to retreat.

Other names: permethrin (5%), malathion (0.5%), lindane (1%)

Primary outcomes

  1. Number of Participants Free of Live Head Lice and Free of Viable Eggs

    Time frame: Day after first treatment and Day 14 of study

    A determination of head lice effectiveness, measured by number of subjects free of live lice and by number of subjects free of viable eggs, was calculated using two week post-treatment data as the primary study outcome. Measurements were calculated at Day 1 (day after first treatment) and Day 14.

    At diagnosis, 55 subjects had viable eggs with three subjects meeting enrollment criteria for three or more live lice.

Sponsors and collaborators

Lead sponsor

Hackensack Meridian Health

Other

Registry information

Official study title

Safety and Efficacy of a 100% Dimethicone Pediculocide in School-Age Children

Important dates

Study start
2009
Primary completion
2014
Study completion
2014
First posted
Aug 11, 2014
Registry last updated
Jul 29, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.